A systematic review of the Treatment and dissemination in vestibular schwannoma: Pearls and Pitfalls for Minimizing Complication

Abstract Background VS account for approximately 6–8% of intracranial tumors in adults and are the most common tumor in the CPA ranging between 80% and 95%. hearing loss associated with vestibular schwannomas of this size is typically unilateral, progressive, and commonly affects high-frequency thresholds and speech perception. Gross total resection is the goal of surgery while maintaining good facial function, in all sizes of tumors, and hearing preservation, in small to moderate size tumors in patients with serviceable preoperative hearing status. We provide an overview of vestibular schwannoma and discuss anatomical factors and their methods and publication, as well as the management strategies we should adopt when they occur. Methods A review was conducted that follows the preferential reporting guidelines. PubMed, EMBASE, Library Genesis were used to search for vestibular schwannoma. Results Vestibular schwannomas constitute 6% of all intracranial neoplasms and are the most common benign lesions of the IAC and CPA cistern constituting between 60% and 90% of the entire lesions seen in this area. Conclusions In the foreseeable future, Play better methods and treatments for vestibular schwannoma management in the age of precision medicine.